Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences

References

• [No authors listed] 2007Rituxan warningFDA Consum413
   Google Scholar
• AbeTTakeuchiTMiyasakaN2006A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritisJ Rheumatol33374416395748
   PubMed Web of Science ®Google Scholar
• AbramsJRLebwohlMGGuzzoCA1999CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgarisJ Clin Invest10312435210225967
   PubMed Web of Science ®Google Scholar
• AllantazFChaussabelDStichwehD2007Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockadeJ Exp Med20421314417724127
   PubMed Web of Science ®Google Scholar
• AndersonGMNakadaMTDeWitteM2004Tumor necrosis factor-alpha in the pathogenesis and treatment of cancerCurr Opin Pharmacol43142015251122
   PubMed Web of Science ®Google Scholar
• AntoniCKruegerGGde VlamK2005aInfliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trialAnn Rheum Dis641150715677701
   PubMed Web of Science ®Google Scholar
• AntoniCEKavanaughAKirkhamB2005bSustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)Arthritis Rheum5212273615818699
   PubMed Web of Science ®Google Scholar
• ArmbrustWKamphuisSSWolfsTW2004Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritisRheumatology (Oxford)43527915024141
   PubMed Web of Science ®Google Scholar
• AsklingJForedCMBaecklundE2005aHaematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonistsAnn Rheum Dis6414142015843454
   PubMed Web of Science ®Google Scholar
• AsklingJForedCMBrandtL2005bRisks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonistsAnn Rheum Dis641421615829572
   PubMed Web of Science ®Google Scholar
• AsklingJForedCMBrandtL2007Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonistsAnn Rheum Dis6613394417261532
   PubMed Web of Science ®Google Scholar
• BaecklundEIliadouAAsklingJ2006Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritisArthritis Rheum5469270116508929
   PubMed Web of Science ®Google Scholar
• BaertFNomanMVermeireS2003Influence of immunogenicity on the long-term efficacy of infliximab in Crohn’s diseaseN Engl J Med348601812584368
   PubMed Web of Science ®Google Scholar
• BendeleAMChlipalaESScherrerJ2000Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritisArthritis Rheum4326485911145022
   PubMed Web of Science ®Google Scholar
• BendtzenKGeborekPSvensonM2006Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximabArthritis Rheum543782917133559
   PubMed Web of Science ®Google Scholar
• BennettCMRogersZRKinnamonDD2006Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraBlood10726394216352811
   PubMed Web of Science ®Google Scholar
• BernatskySHudsonMSuissaS2007Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritisRheumatology (Oxford)4611576017478469
   PubMed Web of Science ®Google Scholar
• BiesterSDeuterCMichelsH2007Adalimumab in the therapy of uveitis in childhoodBr J Ophthalmol913192417035274
   PubMed Web of Science ®Google Scholar
• BilliauADCornillieFWoutersC2002Infliximab for systemic onset juvenile idiopathic arthritis: experience in 3 childrenJ Rheumatol291111412022340
   PubMed Web of Science ®Google Scholar
• BluestoneJASt ClairEWTurkaLA2006CTLA4Ig: bridging the basic immunology with clinical applicationImmunity24233816546089
   PubMed Web of Science ®Google Scholar
• BongartzTSuttonAJSweetingMJ2006Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trialsJAMA29522758516705109
   PubMed Web of Science ®Google Scholar
• BrandtJKhariouzovAListingJ2003Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitisArthritis Rheum4816677512794835
   PubMed Web of Science ®Google Scholar
• BraunJDavisJDougadosM2006First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitisAnn Rheum Dis653162016096329
   PubMed Web of Science ®Google Scholar
• BreedveldFCWeismanMHKavanaughAF2006The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatmentArthritis Rheum54263716385520
   PubMed Web of Science ®Google Scholar
• BresnihanBAlvaro-GraciaJMCobbyM1998Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonistArthritis Rheum4121962049870876
   PubMed Web of Science ®Google Scholar
• [BTS] British Thoracic Society Standards of Care Committee2005BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatmentThorax60800516055611
   PubMed Web of Science ®Google Scholar
• BrownSLGreeneMHGershonSK2002Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug AdministrationArthritis Rheum463151812483718
   PubMed Web of Science ®Google Scholar
• BrulhartLCiureaAFinckhA2006Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational studyAnn Rheum Dis651255716540545
   PubMed Web of Science ®Google Scholar
• Burgos-VargasRCasasola-VargasJGutierrez-SuarezR2007Efficacy, safety, and tolerability of infliximab in juvenile-onset spondyloarthropathies (JO-SpA): results of the three-month, randomized, double-blind, placebo-controlled trial phase [abstract]Arthritis Rheum56supplS319
   Google Scholar
• Burgos-VargasRRudwaleitMSieperJ2002aThe place of juvenile onset spondyloarthropathies in the Durban 1997 ILAR classification criteria of juvenile idiopathic arthritis. International League of Associations for RheumatologyJ Rheumatol298697412022342
   PubMed Web of Science ®Google Scholar
• Burgos-VargasRVazquez-MelladoJPacheco-TenaC2002bA 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathiesAnn Rheum Dis61941212228171
   PubMed Web of Science ®Google Scholar
• CalinADijkmansBAEmeryP2004Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitisAnn Rheum Dis63159460015345498
   PubMed Web of Science ®Google Scholar
• CampionGVLebsackMELookabaughJ1996Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study GroupArthritis Rheum3910921018670316
   PubMed Web of Science ®Google Scholar
• CarmonaLGomez-ReinoJJRodriguez-ValverdeV2005Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonistsArthritis Rheum5217667215934089
   PubMed Web of Science ®Google Scholar
• CarswellEAOldLJKasselRL1975An endotoxin-induced serum factor that causes necrosis of tumorsProc Natl Acad Sci USA723666701103152
   PubMed Web of Science ®Google Scholar
• ChadhaTHernandezJE2006Infliximab-related lupus and associated valvulitis: a case report and review of the literatureArthritis Rheum55163616463396
   PubMed Web of Science ®Google Scholar
• CheifetzAMayerL2005Monoclonal antibodies, immunogenicity, and associated infusion reactionsMt Sinai J Med72250616021319
   PubMed Web of Science ®Google Scholar
• ChenJLiuC2006Is sulfasalazine effective in ankylosing spondylitis? A systematic review of randomized controlled trialsJ Rheumatol337223116583475
   PubMed Web of Science ®Google Scholar
• ChoyEHIsenbergDAGarroodT2002Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trialArthritis Rheum4631435012483717
   PubMed Web of Science ®Google Scholar
• CohenJDBourneriasIBuffardV2007Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case seriesJ Rheumatol34380517013997
   PubMed Web of Science ®Google Scholar
• CohenSHurdECushJ2002Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trialArthritis Rheum466142411920396
   PubMed Web of Science ®Google Scholar
• CohenSB2004The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritisRheum Dis Clin North Am30365380vii15172046
   PubMed Web of Science ®Google Scholar
• CohenSBEmeryPGreenwaldMW2006Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeksArthritis Rheum54279380616947627
   PubMed Web of Science ®Google Scholar
• CohenSBMorelandLWCushJJ2004A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexateAnn Rheum Dis631062815082469
   PubMed Web of Science ®Google Scholar
• CrandallWVMacknerLM2003Infusion reactions to infliximab in children and adolescents: frequency, outcome and a predictive modelAliment Pharmacol Ther17758412492735
   PubMed Web of Science ®Google Scholar
• CurtisJRPatkarNXieA2007Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonistsArthritis Rheum5611253317393394
   PubMed Web of Science ®Google Scholar
• DassSVitalEMEmeryP2007Development of psoriasis after B cell depletion with rituximabArthritis Rheum5627151817665440
   PubMed Web of Science ®Google Scholar
• DavisJCJrVan Der HeijdeDBraunJ2003Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trialArthritis Rheum483230614613288
   PubMed Web of Science ®Google Scholar
• De BandtMSibiliaJLe LoetX2005Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national surveyArthritis Res Ther7R5455115899041
   PubMed Web of Science ®Google Scholar
• de BenedettiFMassaMRobbioniP1991Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritisArthritis Rheum341158631930333
   PubMed Web of Science ®Google Scholar
• De MarcoGGerloniVPontikakiI2007[Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy.]Reumatismo5950617435842
   PubMedGoogle Scholar
• DinarelloCA1996Biologic basis for interleukin-1 in diseaseBlood8720951478630372
   PubMed Web of Science ®Google Scholar
• DixonWSilmanA2006Is there an association between anti-TNF monoclonal antibody therapy in rheumatoid arthritis and risk of malignancy and serious infection? Commentary on the meta-analysis by Bongartz et alArthritis Res Ther811116911768
   PubMed Web of Science ®Google Scholar
• DixonWGSymmonsDPLuntM2007Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: Lessons from interpreting data from observational studiesArthritis Rheum56289690417763441
   PubMed Web of Science ®Google Scholar
• DixonWGWatsonKLuntM2006Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics RegisterArthritis Rheum5423687616868999
   PubMed Web of Science ®Google Scholar
• DoranMFCrowsonCSPondGR2002Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based studyArthritis Rheum4622879312355475
   PubMed Web of Science ®Google Scholar
• EdwardsJCSzczepanskiLSzechinskiJ2004Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritisN Engl J Med35025728115201414
   PubMed Web of Science ®Google Scholar
• EisenbergSPEvansRJArendWP1990Primary structure and functional expression from complementary DNA of a human interleu-kin-1 receptor antagonistNature34334162137201
   PubMed Web of Science ®Google Scholar
• El-HallakMBinstadtBALeichtnerAM2007Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseasesJ Pediatr1503768217382113
   PubMed Web of Science ®Google Scholar
• ElliottMJMainiRNFeldmannM1994Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritisLancet3441105107934491
   PubMed Web of Science ®Google Scholar
• ElliottMJWooPCharlesP1997Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-alpha (cA2)Br J Rheumatol36589939189062
   PubMedGoogle Scholar
• EmeryPFleischmannRFilipowicz-SosnowskaA2006The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trialArthritis Rheum54139040016649186
   PubMed Web of Science ®Google Scholar
• FeigeUHuYLGasserJ2000Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis ratsCell Mol Life Sci5714577011078023
   PubMed Web of Science ®Google Scholar
• FeldmannMBrennanFMWilliamsRO2004The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritisBest Pract Res Clin Rheumatol18598015123038
   PubMed Web of Science ®Google Scholar
• Ferraro-PeyretCCouryFTebibJG2004Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective studyArthritis Res Ther6R5354315535831
   PubMed Web of Science ®Google Scholar
• FerucciEDMajkaDSParrishLA2005Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritisArthritis Rheum522394615641089
   PubMed Web of Science ®Google Scholar
• FinckhACiureaABrulhartL2007B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agentsArthritis Rheum5614172317469098
   PubMed Web of Science ®Google Scholar
• FishmanDFauldsGJefferyR1998The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritisJ Clin Invest1021369769769329
   PubMed Web of Science ®Google Scholar
• FitzgeraldAALeclercqSAYanA2005Rapid responses to anakinra in patients with refractory adult-onset Still’s diseaseArthritis Rheum52179480315934079
   PubMed Web of Science ®Google Scholar
• FleischmannRMSchechtmanJBennettR2003Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trialArthritis Rheum489273412687534
   PubMed Web of Science ®Google Scholar
• FleischmannRMTesserJSchiffMH2006Safety of extended treatment with anakinra in patients with rheumatoid arthritisAnn Rheum Dis6510061216396977
   PubMed Web of Science ®Google Scholar
• FoeldvariINielsenSKummerle-DeschnerJ2007Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational surveyJ Rheumatol3411465017343318
   PubMed Web of Science ®Google Scholar
• FranklinJLuntMBunnD2006Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritisAnn Rheum Dis656172216249224
   PubMed Web of Science ®Google Scholar
• FranklinJPSymmonsDPSilmanAJ2005Risk of lymphoma in patients with RA treated with anti-TNFalpha agentsAnn Rheum Dis64657815834052
   PubMed Web of Science ®Google Scholar
• Freim WahlSGFolvikMRTorpSH2007Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: case report and review of the literatureClin Neuropathol26687317416105
   PubMed Web of Science ®Google Scholar
• FurstDECushJKaufmannS2002Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agentsAnn Rheum Dis61Suppl 2ii62312379625
   PubMedGoogle Scholar
• FurstDESchiffMHFleischmannRM2003Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)J Rheumatol3025637114719195
   PubMed Web of Science ®Google Scholar
• FusconiMVanniniADall’aglioAC2007Etanercept and infliximab induce the same serological autoimmune modifications in patients with rheumatoid arthritisRheumatol Int2847917564711
   PubMed Web of Science ®Google Scholar
• GartlehnerGHansenRAJonasBL2006The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysisJ Rheumatol33239840817225293
   PubMed Web of Science ®Google Scholar
• GartlehnerGHansenRAJonasBL2008Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidenceClin Rheumatol27677617570009
   PubMed Web of Science ®Google Scholar
• GeborekPBladstromATuressonC2005Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomasAnn Rheum Dis6469970315695534
   PubMed Web of Science ®Google Scholar
• GenoveseMBreedveldFCEmeryP2006TNF inhibitors in rheumatoid arthritis patients previously treated with rituximab [abstract]Arthritis Rheum54supplS329
   Google Scholar
• GenoveseMCBeckerJCSchiffM2005Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibitionN Engl J Med35311142316162882
   PubMed Web of Science ®Google Scholar
• GenoveseMCCohenSMorelandL2004Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexateArthritis Rheum501412915146410
   PubMed Web of Science ®Google Scholar
• GenoveseMCMeasePJThomsonGT2007Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapyJ Rheumatol3410405017444593
   PubMed Web of Science ®Google Scholar
• GenslerLDavisJCJr2006Recognition and treatment of juvenile-onset spondyloarthritisCurr Opin Rheumatol185071116896291
   PubMed Web of Science ®Google Scholar
• GerloniVPontikakiIGattinaraM2005Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective studyArthritis Rheum525485315693004
   PubMed Web of Science ®Google Scholar
• GoldbergSLPecoraALAlterRS2002Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximabBlood991486811830505
   PubMed Web of Science ®Google Scholar
• Gomez-ReinoJJCarmonaLValverdeVR2003Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance reportArthritis Rheum482122712905464
   PubMed Web of Science ®Google Scholar
• GottenbergJEGuillevinLLambotteO2005Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseasesAnn Rheum Dis649132015550531
   PubMed Web of Science ®Google Scholar
• Grillo-LopezAJWhiteCAVarnsC1999Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphomaSemin Oncol26667310561020
   PubMed Web of Science ®Google Scholar
• HaibelHBrandtHCSongIH2007No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trialAnn Rheum Dis664192116901959
   PubMed Web of Science ®Google Scholar
• HashkesPJLaxerRM2006Update on the medical treatment of juvenile idiopathic arthritisCurr Rheumatol Rep8450817092444
   PubMedGoogle Scholar
• HenricksonMReiffA2004Prolonged efficacy of etanercept in refractory enthesitis-related arthritisJ Rheumatol3120556115468375
   PubMed Web of Science ®Google Scholar
• HigashidaJWunTSchmidtS2005Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatmentJ Rheumatol3221091516265687
   PubMed Web of Science ®Google Scholar
• HopkinsSJMeagerA1988Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferonClin Exp Immunol7388922458872
   PubMed Web of Science ®Google Scholar
• HorneffGSchmelingHBiedermannT2004The German etanercept registry for treatment of juvenile idiopathic arthritisAnn Rheum Dis6316384415115709
   PubMed Web of Science ®Google Scholar
• HuangJLChenLC1998Sulphasalazine in the treatment of children with chronic arthritisClin Rheumatol17359639805178
   PubMed Web of Science ®Google Scholar
• IlowiteNReiffARudgeS2006A randomized, multicenter, blinded, placebo-controlled study with an open-label run-in period to evaluate anakinra in polyarticular-course juvenile rheumatoid arthritis [abstract]Arthritis Rheum54SupplS32728
   Google Scholar
• IlowiteNTPorrasOReiffA2003A twelve-week open label safety and efficacy study of anakinra (Kineret) in juvenile rheumatoid arthritis [abstract]Ann Rheum Dis62suppl 187
   Google Scholar
• ImagawaTMoriMTakeiS2006Efficacy and safety of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in patients with polyarticular or oligoarticular onset juvenile idiopathic arthritis [abstract]Arthritis Rheum54supplS168
   Google Scholar
• IrigoyenPIOlsonJHomC2004Treatment of systemic onset juvenile rheumatoid arthritis with anakinra [abstract]Arthritis Rheum50supplS437
   Google Scholar
• IsaacsJDMorganAWStrandV1999Combination biologic therapyClin Exp Rheumatol17S121410589370
   PubMed Web of Science ®Google Scholar
• JiangYGenantHKWattI2000A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scoresArthritis Rheum431001910817552
   PubMed Web of Science ®Google Scholar
• JoisRNMasdingASomervilleM2007Rituximab therapy in patients with resistant rheumatoid arthritis: real-life experienceRheumatology (Oxford)46980217384180
   PubMed Web of Science ®Google Scholar
• KahnPWeissMImundoLF2006Favorable response to high-dose infliximab for refractory childhood uveitisOphthalmology1138604 e216545455
   PubMed Web of Science ®Google Scholar
• KallioliasGDGeorgiouPEAntonopoulosIA2007Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trialAnn Rheum Dis66842317513574
   PubMed Web of Science ®Google Scholar
• KapetanovicMCLarssonLTruedssonL2006Predictors of infusion reactions during infliximab treatment in patients with arthritisArthritis Res Ther8R13116869978
   PubMed Web of Science ®Google Scholar
• KatsicasMMRussoRA2005Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanerceptClin Exp Rheumatol23545816095128
   PubMed Web of Science ®Google Scholar
• KaurNMahlTC2007Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 casesDig Dis Sci521481417429728
   PubMed Web of Science ®Google Scholar
• KavanaughASt ClairEWMcCuneWJ2000Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapyJ Rheumatol278415010782805
   PubMed Web of Science ®Google Scholar
• KestemanTYombiJCGigiJ2007Listeria infections associated with infliximab: case reportsClin Rheumatol262173517579802
   PubMed Web of Science ®Google Scholar
• KeystoneEC2005Safety of biologic therapies--an updateJ Rheumatol Suppl7481215742458
   PubMedGoogle Scholar
• KeystoneECKavanaughAFSharpJT2004aRadiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trialArthritis Rheum5014001115146409
   PubMed Web of Science ®Google Scholar
• KeystoneECSchiffMHKremerJM2004bOnce-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trialArthritis Rheum503536314872476
   PubMed Web of Science ®Google Scholar
• KietzDAPepmuellerPHMooreTL2002Therapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two year periodAnn Rheum Dis61171311796406
   PubMed Web of Science ®Google Scholar
• KimbyE2005Tolerability and safety of rituximab (MabThera)Cancer Treat Rev314567316054760
   PubMed Web of Science ®Google Scholar
• KimuraYPinhoPWalcoG2005Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritisJ Rheumatol329354215868633
   PubMed Web of Science ®Google Scholar
• KinderAStephensSMortimerN2004Severe herpes zoster after infliximab infusionPostgrad Med J802614760175
   PubMedGoogle Scholar
• KlareskogLvan der HeijdeDde JagerJP2004Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trialLancet3636758115001324
   PubMed Web of Science ®Google Scholar
• KneitzCWilhelmMTonyHP2004Improvement of refractory rheumatoid arthritis after depletion of B cellsScand J Rheumatol3382615163108
   PubMed Web of Science ®Google Scholar
• Kone-PautIRetornazKGarnierJM2007Visceral leishmaniasis in a patient with systemic juvenile arthritis treated by IL-1RA agonist (Anakinra)Clin Exp Rheumatol2511917418007
   PubMed Web of Science ®Google Scholar
• KotterIWackerAKochS2007Anakinra in patients with treatment-resistant adult-onset still’s disease: Four case reports with serial cytokine measurements and a review of the literatureSemin Arthritis Rheum371899717583775
   PubMed Web of Science ®Google Scholar
• KremerJMDougadosMEmeryP2005Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelvemonth results of a phase iib, double-blind, randomized, placebo-controlled trialArthritis Rheum5222637116052582
   PubMed Web of Science ®Google Scholar
• KremerJMGenantHKMorelandLW2006Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trialAnn Intern Med1448657616785475
   PubMed Web of Science ®Google Scholar
• KremerJMWesthovensRLeonM2003Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4IgN Engl J Med34919071514614165
   PubMed Web of Science ®Google Scholar
• KroesenSWidmerAFTyndallA2003Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapyRheumatology (Oxford)426172112709536
   PubMed Web of Science ®Google Scholar
• Krumrey-LangkammererMHafnerR2001Evaluation of the ILAR criteria for juvenile idiopathic arthritisJ Rheumatol282544711708431
   PubMed Web of Science ®Google Scholar
• KuekAHazlemanBLGastonJH2006Successful treatment of refractory polyarticular juvenile idiopathic arthritis with rituximabRheumatology (Oxford)451448916920752
   PubMed Web of Science ®Google Scholar
• Kuemmerle-DeschnerJBHorneffG2007Safety and efficacy of once weekly application of Etanercept in children with juvenile idiopathic arthritisRheumatol Int28153617641897
   PubMed Web of Science ®Google Scholar
• LahdennePVahasaloPHonkanenV2003Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label studyAnn Rheum Dis62245712594111
   PubMed Web of Science ®Google Scholar
• LanJLChouSJChenDY2004A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled studyJ Formos Med Assoc1036182315340661
   PubMed Web of Science ®Google Scholar
• LeandroMJCambridgeGEhrensteinMR2006Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritisArthritis Rheum546132016447239
   PubMed Web of Science ®Google Scholar
• LeandroMJEdwardsJCCambridgeG2002Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletionAnn Rheum Dis61883812228157
   PubMed Web of Science ®Google Scholar
• LehmanTJ2007The future of pediatric rheumatology: Many questions remainArthritis Rheum5628151617763434
   PubMed Web of Science ®Google Scholar
• LeporeLMarchettiFFacchiniS2003Drug-induced systemic lupus erythematosus associated with etanercept therapy in a child with juvenile idiopathic arthritisClin Exp Rheumatol21276712747299
   PubMed Web of Science ®Google Scholar
• LequerreTQuartierPRoselliniD2008Interleukin-1 receptor antagonist (Anakinra) treatment with patients with systemic-onset juvenile idiopathic arthritis or adult onset Still’s disease: preliminary experience in FranceAnn Rheum Dis67302817947302
   PubMed Web of Science ®Google Scholar
• LinsleyPSBradyWUrnesM1991CTLA-4 is a second receptor for the B cell activation antigen B7J Exp Med17456191714933
   PubMed Web of Science ®Google Scholar
• LipskyPEvan der HeijdeDMSt ClairEW2000Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study GroupN Engl J Med343159460211096166
   PubMed Web of Science ®Google Scholar
• ListingJStrangfeldAKaryS2005Infections in patients with rheumatoid arthritis treated with biologic agentsArthritis Rheum5234031216255017
   PubMed Web of Science ®Google Scholar
• LovellDRupertoNJungL2006aLong-term efficacy and safety of adalimumab in children with juvenile rheumatoid arthritis (JRA): 48-week results [abstract]Arthritis Rheum54supplS329
   Google Scholar
• LovellDJ2006Update on treatment of arthritis in children: new treatments, new goalsBull NYU Hosp Jt Dis6472617121494
   PubMedGoogle Scholar
• LovellDJGianniniEHReiffA2000Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study GroupN Engl J Med342763910717011
   PubMed Web of Science ®Google Scholar
• LovellDJReiffAJonesOY2006bLong-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritisArthritis Rheum5419879416732547
   PubMed Web of Science ®Google Scholar
• LovellDJRupertoNPrieurAM2006cassessment of open label co-stimulation blockade with abatacept in children and adolescents with active juvenile idiopathic arthritis (JIA) [abstract]Arthritis Rheum54SupplS326
   Google Scholar
• LovellDJRupertoNPrieurAM2007Abatacept treatment of juvenile idiopathic arthritis (JIA): safety report [abstract]Arthritis Rheum56SupplS292
   Google Scholar
• MainiRNBreedveldFCKaldenJR1998Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritisArthritis Rheum411552639751087
   PubMed Web of Science ®Google Scholar
• MainiRNTaylorPCSzechinskiJ2006Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexateArthritis Rheum5428172916947782
   PubMed Web of Science ®Google Scholar
• MannersPJBowerC2002Worldwide prevalence of juvenile arthritis why does it vary so much?J Rheumatol2915203012136914
   PubMed Web of Science ®Google Scholar
• MarietteXSalmonD2003French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockersAnn Rheum Dis6279112860745
   PubMed Web of Science ®Google Scholar
• MarksSDPateySBroganPA2005B lymphocyte depletion therapy in children with refractory systemic lupus erythematosusArthritis Rheum5231687416200620
   PubMed Web of Science ®Google Scholar
• Marzo-OrtegaHMcGonagleDJarrettS2005Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging studyAnn Rheum Dis6415687515829577
   PubMed Web of Science ®Google Scholar
• MatsubaraTHasegawaMShiraishiM2006A severe case of chronic infantile neurologic, cutaneous, articular syndrome treated with biologic agentsArthritis Rheum5423142016802372
   PubMed Web of Science ®Google Scholar
• MatteucciPMagniMDi NicolaM2002Leukoencephalopathy and papovavirus infection after treatment with chemotherapy and anti-CD20 monoclonal antibodyBlood1001104512150156
   PubMed Web of Science ®Google Scholar
• MeasePJGladmanDDRitchlinCT2005Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trialArthritis Rheum5232798916200601
   PubMed Web of Science ®Google Scholar
• MeasePJGoffeBSMetzJ2000Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trialLancet3563859010972371
   PubMed Web of Science ®Google Scholar
• MindenKKiesslingUListingJ2000Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathyJ Rheumatol2722566310990244
   PubMed Web of Science ®Google Scholar
• MohrbacherA2005B cell non-Hodgkin’s lymphoma: rituximab safety experienceArthritis Res Ther7Suppl 3S192515960818
   PubMed Web of Science ®Google Scholar
• MooreJMaDWillR2004A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantationBone Marrow Transplant34241715235579
   PubMed Web of Science ®Google Scholar
• MorABinghamC3rdBarisoniL2005Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanerceptJ Rheumatol32740315801034
   PubMed Web of Science ®Google Scholar
• MorelandLWAltenRVan den BoschF2002Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusionArthritis Rheum461470912115176
   PubMed Web of Science ®Google Scholar
• MorelandLWBaumgartnerSWSchiffMH1997Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion proteinN Engl J Med33714179219699
   PubMed Web of Science ®Google Scholar
• MorelandLWSchiffMHBaumgartnerSW1999Etanercept therapy in rheumatoid arthritis. A randomized, controlled trialAnn Intern Med1304788610075615
   PubMed Web of Science ®Google Scholar
• NishimotoNHashimotoJMiyasakaN2007Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumabAnn Rheum Dis661162717485422
   PubMed Web of Science ®Google Scholar
• NishimotoNYoshizakiKMiyasakaN2004Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trialArthritis Rheum501761915188351
   PubMed Web of Science ®Google Scholar
• NorambuenaRXMallolJRiosMG2007Therapeutic effects of the anti-tumor necrosis factor monoclonal antibody, infliximab, in four children with refractory juvenile idiopathic arthritisAllergol Immunopathol (Madr)3552617428400
   PubMed Web of Science ®Google Scholar
• OgilvieEMFifeMSThompsonSD2003The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis familiesArthritis Rheum483202614613283
   PubMed Web of Science ®Google Scholar
• OgilvieEMKhanAHubankM2007Specific gene expression profiles in systemic juvenile idiopathic arthritisArthritis Rheum5619546517530721
   PubMed Web of Science ®Google Scholar
• ParodiENobiliBPerrottaS2006Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatmentInt J Hematol84485316867902
   PubMed Web of Science ®Google Scholar
• PascualVAllantazFArceE2005Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockadeJ Exp Med20114798615851489
   PubMed Web of Science ®Google Scholar
• PeekRScott-JuppRStrikeH2006Psoriasis after treatment of juvenile idiopathic arthritis with etanerceptAnn Rheum Dis65125916905590
   PubMed Web of Science ®Google Scholar
• PettyRESouthwoodTRMannersP2004International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001J Rheumatol31390214760812
   PubMed Web of Science ®Google Scholar
• PijpeJvan ImhoffGWSpijkervetFK2005Rituximab treatment in patients with primary Sjogren’s syndrome: an open-label phase II studyArthritis Rheum5227405016142737
   PubMed Web of Science ®Google Scholar
• PincusTSteinCM1997Why randomized controlled clinical trials do not depict accurately long-term outcomes in rheumatoid arthritis: some explanations and suggestions for future studiesClin Exp Rheumatol15Suppl 17S27389266130
   PubMed Web of Science ®Google Scholar
• PirardDArcoDDebrouckereV2006Anti-tumor necrosis factor alpha-induced psoriasiform eruptions: three further cases and current overviewDermatology213182617033165
   PubMed Web of Science ®Google Scholar
• PopaCLeandroMJCambridgeG2007Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrsRheumatology (Oxford)466263017189244
   PubMed Web of Science ®Google Scholar
• PrescottKCostnerMCohenS2007Tumor necrosis factor-alpha inhibitor associated ulcerative colitisAm J Med Sci333137917496730
   PubMed Web of Science ®Google Scholar
• PrinceFHTwiltMJansen-WijngaardenNC2007Effectiveness of a once weekly double dose of etanercept in patients with juvenile idiopathic arthritis: a clinical studyAnn Rheum Dis66704517324973
   PubMed Web of Science ®Google Scholar
• QuartierPBrethonBPhilippetP2001Treatment of childhood auto-immune haemolytic anaemia with rituximabLancet3581511311705566
   PubMed Web of Science ®Google Scholar
• QuartierPTaupinPBourdeautF2003Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset typeArthritis Rheum48109310112687553
   PubMed Web of Science ®Google Scholar
• QuartuccioLDe VitaS2007Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult onset Still’s diseaseJ Rheumatol34892317407250
   PubMed Web of Science ®Google Scholar
• QuinnMAConaghanPGO’ConnorPJ2005Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trialArthritis Rheum52273515641102
   PubMed Web of Science ®Google Scholar
• RajaramanRTKimuraYLiS2006Retrospective case review of pediatric patients with uveitis treated with infliximabOphthalmology1133081416406545
   PubMed Web of Science ®Google Scholar
• Ramos-CasalsMBrito-ZeronPMunozS2007Autoimmune diseases induced by tnf-targeted therapies: Analysis of 233 casesMedicine (Baltimore)862425117632266
   PubMed Web of Science ®Google Scholar
• RankinECChoyEHKassimosD1995The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritisBr J Rheumatol34334427788147
   PubMedGoogle Scholar
• RaoAKellyMMusselmanM2007Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopeniasPediatr Blood Cancer50822517570702
   PubMed Web of Science ®Google Scholar
• ReiffATakeiSSadeghiS2001Etanercept therapy in children with treatment-resistant uveitisArthritis Rheum441411511407702
   PubMed Web of Science ®Google Scholar
• RichardsJCTay-KearneyMLMurrayK2005Infliximab for juvenile idiopathic arthritis-associated uveitisClin Experiment Ophthalmol33461816181269
   PubMed Web of Science ®Google Scholar
• RigbyWF2007Drug insight: different mechanisms of action of tumor necrosis factor antagonists-passive-aggressive behavior?Nat Clin Pract Rheumatol32273317396108
   PubMedGoogle Scholar
• RooneyMDavidJSymonsJ1995Inflammatory cytokine responses in juvenile chronic arthritisBr J Rheumatol34454607788176
   PubMedGoogle Scholar
• RuizPJMasliahEDohertyTA2007Cardiac death in a patient with adult-onset Still’s disease treated with the interleukin 1 receptor inhibitor anakinraAnn Rheum Dis66422317179171
   PubMed Web of Science ®Google Scholar
• RupertoNLovellDJCutticaR2007A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritisArthritis Rheum56309610617763439
   PubMed Web of Science ®Google Scholar
• RussoRAKatsicasMMZelazkoM2002Etanercept in systemic juvenile idiopathic arthritisClin Exp Rheumatol20723612412209
   PubMed Web of Science ®Google Scholar
• Saint MarcouxBDe BandtM2006Vasculitides induced by TNFalpha antagonists: a study in 39 patients in FranceJoint Bone Spine737101317127088
   PubMed Web of Science ®Google Scholar
• SalliotCGossecLRuyssen-WitrandA2007Infections during tumour necrosis factor-alpha blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patientsRheumatology (Oxford)463273416880188
   PubMed Web of Science ®Google Scholar
• SalomonBBluestoneJA2001Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantationAnnu Rev Immunol192255211244036
   PubMed Web of Science ®Google Scholar
• Sampaio-BarrosPDCostallatLTBertoloMB2000Methotrexate in the treatment of ankylosing spondylitisScand J Rheumatol29160210898067
   PubMed Web of Science ®Google Scholar
• SatoKTsuchiyaMSaldanhaJ1993Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growthCancer Res5385168428365
   PubMed Web of Science ®Google Scholar
• SaurenmannRKLevinAVRoseJB2006Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitisRheumatology (Oxford)45982916461435
   PubMed Web of Science ®Google Scholar
• SaxenaNMisraRAggarwalA2006Is the enthesitis-related arthritis subtype of juvenile idiopathic arthritis a form of chronic reactive arthritis?Rheumatology (Oxford)4511293216522678
   PubMed Web of Science ®Google Scholar
• SchallerJKupferCWedgwoodRJ1969Iridocyclitis in juvenile rheumatoid arthritisPediatrics44921004978557
   PubMed Web of Science ®Google Scholar
• ScheinbergMHamerschlakNKutnerJM2006Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002–2004)Clin Exp Rheumatol2465916539821
   PubMed Web of Science ®Google Scholar
• SchmelingHHorneffG2004Infliximab in two patients with juvenile ankylosing spondylitisRheumatol Int24173614648110
   PubMed Web of Science ®Google Scholar
• SchmelingHHorneffG2005Etanercept and uveitis in patients with juvenile idiopathic arthritisRheumatology (Oxford)4410081115855187
   PubMed Web of Science ®Google Scholar
• SchneeweissSSetoguchiSWeinblattME2007Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritisArthritis Rheum5617546417530704
   PubMed Web of Science ®Google Scholar
• SetoguchiSSolomonDHWeinblattME2006Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritisArthritis Rheum5427576416947774
   PubMed Web of Science ®Google Scholar
• SettasLDTsimirikasGVosvotekasG2007Reactivation of pulmonary tuberculosis in a patient with rheumatoid arthritis during treatment with IL-1 receptor antagonists (anakinra)J Clin Rheumatol132192017762459
   PubMed Web of Science ®Google Scholar
• SicotteNLVoskuhlRR2001Onset of multiple sclerosis associated with anti-TNF therapyNeurology571885811723281
   PubMed Web of Science ®Google Scholar
• SiddiquiMA2007The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidenceCurr Opin Rheumatol193081317414961
   PubMed Web of Science ®Google Scholar
• SmithJAThompsonDJWhitcupSM2005A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritisArthritis Rheum53182315696578
   PubMed Web of Science ®Google Scholar
• SmolenJSBeaulieuARubbert-RothA2008Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trialLancet3719879718358926
   PubMed Web of Science ®Google Scholar
• SmolenJSKeystoneECEmeryP2007Consensus statement on the use of rituximab in patients with rheumatoid arthritisAnn Rheum Dis661435017068064
   PubMed Web of Science ®Google Scholar
• Solal-CelignyP2006Safety of rituximab maintenance therapy in follicular lymphomasLeuk Res30Suppl 1S162116750674
   PubMed Web of Science ®Google Scholar
• St ClairEWvan der HeijdeDMSmolenJS2004Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trialArthritis Rheum5034324315529377
   PubMed Web of Science ®Google Scholar
• SteurerMClausenJGotwaldT2003Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximabTransplantation76435612883208
   PubMed Web of Science ®Google Scholar
• TanakaYYamamotoKTakeuchiT2007A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosusMod Rheumatol17191717564773
   PubMedGoogle Scholar
• TannoMNakamuraIKobayashiS2006New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patientsClin Rheumatol259293316328088
   PubMed Web of Science ®Google Scholar
• TaylorPCSteuerAGruberJ2004Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritisArthritis Rheum5011071615077292
   PubMed Web of Science ®Google Scholar
• ThompsonRCDrippsDJEisenbergSP1992Interleukin-1 receptor antagonist (IL-1ra) as a probe and as a treatment for IL-1 mediated diseaseInt J Immunopharmacol14475801535616
   PubMed Web of Science ®Google Scholar
• ThonhoferRGauggMKriessmayrM2005Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatmentAnn Rheum Dis641098915958773
   PubMed Web of Science ®Google Scholar
• ToddDJCostenbaderKHWeinblattMT2007Abatacept in the treatment of rheumatoid arthritisInt J Clin Prac61494500
   PubMed Web of Science ®Google Scholar
• ToddDJHelfgottSM2007Serum sickness following treatment with rituximabJ Rheumatol34430317295433
   PubMed Web of Science ®Google Scholar
• TseSMBurgos-VargasRLaxerRM2005Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathyArthritis Rheum522103815986366
   PubMed Web of Science ®Google Scholar
• TsutsumiYKanamoriHMoriA2005Reactivation of hepatitis B virus with rituximabExpert Opin Drug Saf459960815934864
   PubMedGoogle Scholar
• TubachFRavaudPSalmon-CeronD2006Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonistsClin Infect Dis43e9510017051484
   PubMed Web of Science ®Google Scholar
• TuressonCRiesbeckK2004Septicemia with Staphylococcus aureus, beta-hemolytic streptococci group B and G, and Escherichia coli in a patient with rheumatoid arthritis treated with a recombinant human interleukin 1 receptor antagonist (Anakinra)J Rheumatol31187615338480
   PubMed Web of Science ®Google Scholar
• TynjalaPLindahlPHonkanenV2007Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritisAnn Rheum Dis665485017068061
   PubMed Web of Science ®Google Scholar
• van de PutteLBAtkinsCMalaiseM2004Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failedAnn Rheum Dis635081615082480
   PubMed Web of Science ®Google Scholar
• van de PutteLBRauRBreedveldFC2003Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II studyAnn Rheum Dis6211687714644854
   PubMed Web of Science ®Google Scholar
• van den BergWB2002Is there a rationale for combined TNF and IL-1 blocking in arthritis?Clin Exp Rheumatol20S21514989425
   PubMed Web of Science ®Google Scholar
• Van Den BoschFKruithofEBaetenD2002Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathyArthritis Rheum467556511920412
   PubMed Web of Science ®Google Scholar
• van der HeijdeDDa SilvaJCDougadosM2006aEtanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitisAnn Rheum Dis651572716968715
   PubMed Web of Science ®Google Scholar
• van der HeijdeDDijkmansBGeusensP2005Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT)Arthritis Rheum525829115692973
   PubMed Web of Science ®Google Scholar
• van der HeijdeDKivitzASchiffMH2006bEfficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trialArthritis Rheum5421364616802350
   PubMed Web of Science ®Google Scholar
• van EdeAden BroederAWagenaarM2007Etanercept-related extensive pulmonary nodulosis in a patient with rheumatoid arthritisJ Rheumatol341590217610313
   PubMed Web of Science ®Google Scholar
• Vasques GodinhoFMParreira SantosMJCanas da SilvaJ2005Refractory adult onset Still’s disease successfully treated with anakinraAnn Rheum Dis64647815374853
   PubMed Web of Science ®Google Scholar
• Vazquez-CobianLBFlynnTLehmanTJ2006Adalimumab therapy for childhood uveitisJ Pediatr149572517011337
   PubMed Web of Science ®Google Scholar
• VerbskyJWWhiteAJ2004Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritisJ Rheumatol312071515468378
   PubMed Web of Science ®Google Scholar
• VerschuerenKVan EsscheEVerschuerenP2007Development of sarcoidosis in etanercept-treated rheumatoid arthritis patientsClin Rheumatol2619697117340045
   PubMed Web of Science ®Google Scholar
• WangJWileyJMLuddyR2005Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatmentJ Pediatr1462172115689912
   PubMed Web of Science ®Google Scholar
• WeinblattMCombBCovucciA2006Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled studyArthritis Rheum5428071616947384
   PubMed Web of Science ®Google Scholar
• WeinblattMSchiffMGoldmanA2007Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trialAnn Rheum Dis662283416935912
   PubMed Web of Science ®Google Scholar
• WeinblattMEKeystoneECFurstDE2003Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trialArthritis Rheum48354512528101
   PubMed Web of Science ®Google Scholar
• WeinblattMEKremerJMBankhurstAD1999A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexateN Engl J Med34025399920948
   PubMed Web of Science ®Google Scholar
• WesthovensRYocumDHanJ2006The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: a large, randomized, placebo-controlled trialArthritis Rheum5410758616572442
   PubMed Web of Science ®Google Scholar
• WillemsMHaddadENiaudetP2006Rituximab therapy for childhood-onset systemic lupus erythematosusJ Pediatr1486232716737873
   PubMed Web of Science ®Google Scholar
• WolfeFCaplanLMichaudK2006Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapyArthritis Rheum546283416447241
   PubMed Web of Science ®Google Scholar
• WolfeFMichaudK2004Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patientsArthritis Rheum5017405115188349
   PubMed Web of Science ®Google Scholar
• WolfeFMichaudK2007aBiologic treatment of rheumatoid arthritis and the risk of malignancy: Analyses from a large US observational studyArthritis Rheum5628869517729297
   PubMed Web of Science ®Google Scholar
• WolfeFMichaudK2007bThe effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observationArthritis Rheum561433917469100
   PubMed Web of Science ®Google Scholar
• WooPWilkinsonNPrieurAM2005Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvementArthritis Res Ther7R1281816277681
   PubMed Web of Science ®Google Scholar
• YokotaSImagawaTMoriM2008Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trialLancet371998100618358927
   PubMed Web of Science ®Google Scholar
• YokotaSMiyamaeTImagawaT2005Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritisArthritis Rheum528182515751095
   PubMed Web of Science ®Google Scholar
• ZhouH2005Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion proteinJ Clin Pharmacol45490715831771
   PubMed Web of Science ®Google Scholar
• ZinkAStrangfeldASchneiderM2006Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trialsArthritis Rheum54339940717075823
   PubMed Web of Science ®Google Scholar
• ZwerinaJHayerSTohidast-AkradM2004Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destructionArthritis Rheum502779014730626
   PubMed Web of Science ®Google Scholar